Back to search

Article

Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19

2021-05-18

Abstract excerpt

Computational Drug Repositioning aims at ranking and selecting existing drugs for use in novel diseases or existing diseases for which these drugs were not originally designed. Using vast amounts of available omic data in digital form within an in silico screening has the potential for speeding up considerably the shortlisting of promising candidates in response to outbreaks of diseases such as COVID-19 for which...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d5013d4f-a091-525a-bc16-85b327ef5a35
DOI
10.1101/2021.05.13.21257140
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19DOI 10.1101/2021.05.13.21257140
Select a neighboring publication to make it the new centre.